UPS Healthcare Revolutionizes Prioritized Shipping with Enhancements to UPS® Premier

ATLANTA, July 13, 2022 (GLOBE NEWSWIRE) -- UPS Healthcare (NYSE: UPS) today announced a market expansion and the next generation in the UPS® Premier product line. The UPS® Premier service portfolio provides three-level flexibility to meet healthcare customers' unique needs.

UPS Premier monitors packages at all times, creating visibility and prioritization for each shipment. In addition, sensor technology enables real-time recovery of UPS Premier shipments if they encounter network delays, temperature deviations, or other issues. 

UPS® Premier Silver and Gold are now available in major markets around the world. UPS® Premier Platinum adds the ability to monitor temperature, light and humidity while tracking shipments in and out of the UPS network. UPS Premier Platinum will be available this fall.

“The expansion and enhancement of UPS Premier supports the complex needs of our laboratory, medical and pharmaceutical customers around the world,” said EVP and President International, Healthcare and Supply Chain Solutions Kate Gutmann. “Whether efficiently moving healthcare products between countries, maintaining negative 80-degree temperatures or locating life-saving shipments with precision, UPS Premier provides industry-leading visibility, control, reliability and recovery.”

This specialized service connects major global trade lanes and is now expanding geographically. These new offerings provide customers even more benefits, including efficient customs brokerage, environmental monitoring, and visibility to meet the challenges of global healthcare logistics leaders.

"Visibility and traceability are essential to prioritizing the life-saving medications our customers ship and their customers need," said UPS Healthcare President Wes Wheeler. "The difference between life and death for patients often hinges on the ability to quickly ship and precisely track, monitor and locate medications."

Innovations in biologics, specialty pharmaceuticals, and medications genetically personalized for each patient's needs are driving significant demand for precision logistics to support more patient-critical, time and temperature-sensitive products.

The global market for biologic therapeutic drugs is set to increase from $285.5 billion in 2020 to $421.8 billion by 2025. ¹ UPS Healthcare has added these new UPS Premier capabilities to support the complex needs of this growing market.

For more information on UPS Healthcare's innovations and customer-driven solutions, visit Healthcare.ups.com and about.ups.com.

About UPS Healthcare
UPS Healthcare delivers unparalleled healthcare logistics expertise to its customers around the world. UPS Healthcare has 11+ million square feet of cGMP and GDP-compliant healthcare distribution space globally. Services include inventory management, cold chain packaging and shipping, storage and fulfillment of medical devices, and lab and clinical trial logistics. UPS Healthcare's global infrastructure, its UPS® Premier visibility service, its track and trace technology, and its global quality system are well-suited to meet today's complex logistics demands for the pharmaceutical, medical device, and laboratory diagnostic industries.

About UPS 
UPS (NYSE: UPS) is one of the world’s largest companies, with 2021 revenue of $97.3 billion, and provides a broad range of integrated logistics solutions for customers in more than 220 countries and territories. Focused on its purpose statement, “Moving our world forward by delivering what matters,” the company’s 534,000 employees embrace a strategy that is simply stated and powerfully executed: Customer First. People Led. Innovation Driven. UPS is committed to reducing its impact on the environment and supporting the communities we serve around the world. UPS also takes an unwavering stance in support of diversity, equity and inclusion.  More information can be found at www.ups.com, about.ups.com and www.investors.ups.com.

---

¹ https://www.bccresearch.com/market-research/biotechnology/biologic-therapeutic-drugs-technologies-markets-report.html

UPS Communications
pr@ups.com
404=828-7123